Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vismodegib |
| Trade Name | Erivedge |
| Synonyms | GDC-0449 |
| Drug Descriptions |
Erivedge (vismodegib) binds to and inhibits Smoothened (SMO), resulting in inhibition of downstream signaling and decreased tumor growth (PMID: 24259609, PMID: 19716296). Erivedge (vismodegib) is FDA approved for use in patients with basal cell carcinoma (FDA.gov). |
| DrugClasses | SMO Inhibitor 16 |
| CAS Registry Number | 879085-55-9 |
| NCIT ID | C74038 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| A769662 + Vismodegib | A769662 Vismodegib | 0 | 0 |
| Atezolizumab + Vismodegib | Atezolizumab Vismodegib | 0 | 2 |
| Cytarabine + Vismodegib | Cytarabine Vismodegib | 0 | 1 |
| Gemcitabine + Nab-paclitaxel + Vismodegib | Gemcitabine Nab-paclitaxel Vismodegib | 0 | 1 |
| Metformin + Vismodegib | Metformin Vismodegib | 0 | 0 |
| Pembrolizumab + Vismodegib | Pembrolizumab Vismodegib | 0 | 1 |
| Posaconazole + Vismodegib | Posaconazole Vismodegib | 0 | 0 |
| Ribavirin + Vismodegib | Ribavirin Vismodegib | 0 | 1 |
| RO4929097 + Vismodegib | RO4929097 Vismodegib | 0 | 1 |
| Sirolimus + Vismodegib | Sirolimus Vismodegib | 0 | 1 |
| SP-002 + Vismodegib | SP-002 Vismodegib | 0 | 1 |
| Vismodegib | Vismodegib | 0 | 29 |